1 results match your criteria: "Johns Hopkins University and the Bloomberg Kimmel Institute for Cancer Immunotherapy[Affiliation]"
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison.
Clin Cancer Res
August 2017
Department of Dermatology, Johns Hopkins University and the Bloomberg Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.
PD-L1 expression in the pretreatment tumor microenvironment enriches for response to anti-PD-1/PD-L1 therapies. The purpose of this study was to quantitatively compare the performance of five monoclonal anti-PD-L1 antibodies used in recent landmark publications. PD-L1 IHC was performed on 34 formalin-fixed paraffin-embedded archival melanoma samples using the 5H1, SP142, 28-8, 22C3, and SP263 clones.
View Article and Find Full Text PDF